RITUXIMAB-ABBS

5105 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB-ABBS:

# Side effect Count
0 OFF LABEL USE 2347
1 INTENTIONAL PRODUCT USE ISSUE 347
2 HYPERTENSION 295
3 PAIN 272
4 RHEUMATOID ARTHRITIS 264
5 FATIGUE 261
6 INFUSION RELATED REACTION 251
7 INTENTIONAL DOSE OMISSION 248
8 DYSPNOEA 246
9 PYREXIA 242
See all common reactions for RITUXIMAB-ABBS

RITUXIMAB-ABBS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEILECTOMY 2 0.6667
1 ADMINISTRATION SITE FIBROSIS 2 0.5000
2 AIRWAY PEAK PRESSURE DECREASED 2 0.4000
3 URETHROSCOPY 3 0.3000
4 GARDNERELLA TEST POSITIVE 7 0.2258
5 PERIPROSTHETIC METALLOSIS 3 0.1875
6 NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA 4 0.1290
7 NONINFECTIOUS MYELITIS 6 0.0732
8 WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0714
9 ANTIBIOTIC PROPHYLAXIS 3 0.0682
See all enriched reactions for RITUXIMAB-ABBS